Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Beate Peter has worked on the following 22 EPO patent applications which have been published in the last five years:

EP11702054

IMMUNOGLOBULIN PREPARATION

IPC classification:
A61K 9/00, A61K 39/395, A61K 47/18
Agent:
Beate Peter, CSL Behring GmbH
Status:
EXAMINATION IN PROGRESS
EP11794757

CD89 ACTIVATION IN THERAPY

IPC classification:
A61K 39/395, A61P 37/00, C07K 16/28
Applicant:
University of Bern (Universität Bern)
Agent:
Beate Peter, CSL Behring GmbH
Status:
EXAMINATION IN PROGRESS
EP12167178

Sugar compositions for treating hemophilia a and/or von willebrand disease

IPC classification:
A61K 31/70, A61K 31/7004, A61K 31/7008, A61P 7/04
Applicant:
CSL Behring GmbH
Agent:
Beate Peter, CSL Behring GmbH
Status:
APPLICATION WITHDRAWN
EP11175105

Inhibitory anti-Factor XII/XIIa monoclonal Antibodies and their uses

IPC classification:
C07K 16/36
Applicant:
CSL Behring GmbH
Agent:
Beate Peter, CSL Behring GmbH
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12158939

Treatment of mucositis with Immunoglobulin

IPC classification:
A61P 1/00, C07K 16/06, C07K 16/12
Applicant:
University of Bern (Universität Bern)
Agent:
Beate Peter, CSL Behring GmbH
Status:
APPLICATION REFUSED
EP12158931

Compositions comprising secretory-like immunoglobulins

IPC classification:
A61K 39/395, A61P 31/04, C07K 14/435, C07K 16/06
Agent:
Beate Peter, CSL Behring GmbH
Status:
APPLICATION REFUSED
EP12158927

Process for enriching IgA

IPC classification:
C07K 16/00, C07K 16/06
Agent:
Beate Peter, CSL Behring GmbH
Status:
APPLICATION REFUSED
EP12735916

INHIBITORY ANTI -FACTOR XII/XIIA MONOCLONAL ANTIBODIES AND THEIR USES

IPC classification:
C07K 16/36
Applicant:
CSL Ltd.
Applicant:
CSL Behring GmbH
Agent:
Beate Peter, CSL Behring GmbH
Status:
EXAMINATION IN PROGRESS
EP13164728

Complex

IPC classification:
A61K 38/37, A61K 47/48, A61P 7/04, C07K 14/755
Applicant:
CSL Behring GmbH
Agent:
Beate Peter, CSL Behring GmbH
Status:
GRANT OF PATENT INTENDED
EP11714260

PLASMA-DERIVED IMMUNOGLOBULIN FOR USE IN THE TREATMENT AND PREVENTION OF IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME (IRIS)

IPC classification:
A61P 37/00, C07K 16/00
Applicant:
University Hospital Basel (Universitätsspital Basel)
Agent:
Beate Peter, CSL Behring GmbH
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13704770

VON WILLEBRAND FACTOR VARIANTS HAVING IMPROVED FACTOR VIII BINDING AFFINITY

IPC classification:
A61K 38/36, C07K 14/755, C12N 15/63
Applicant:
CSL Behring GmbH
Agent:
Beate Peter, CSL Behring GmbH
Status:
GRANT OF PATENT INTENDED
EP13708170

TREATMENT OF MUCOSITIS WITH IMMUNOGLOBULIN

IPC classification:
A61P 1/00, C07K 16/06, C07K 16/12
Applicant:
CSL Behring AG
Applicant:
University of Bern (Universität Bern)
Agent:
Beate Peter, CSL Behring GmbH
Status:
EXAMINATION IN PROGRESS
EP13708787

PREVENTION OF INFECTION

IPC classification:
A61K 38/14, A61K 47/48, C07K 16/12
Applicant:
Beth Israel Deaconess Medical Center Inc
Applicant:
CSL Behring AG
Agent:
Beate Peter, CSL Behring GmbH
Status:
GRANT OF PATENT INTENDED
EP13708786

COMPOSITIONS COMPRISING SECRETORY-LIKE IMMUNOGLOBULINS

IPC classification:
A61K 39/395, A61P 31/04, C07K 14/435, C07K 16/06
Applicant:
CSL Behring AG
Agent:
Beate Peter, CSL Behring GmbH
Status:
GRANT OF PATENT INTENDED
EP13708164

PROCESS FOR ENRICHING IGA

IPC classification:
C07K 16/00, C07K 16/06
Applicant:
CSL Behring AG
Agent:
Beate Peter, CSL Behring GmbH
Status:
GRANT OF PATENT INTENDED
EP13709917

SUGAR COMPOSITIONS FOR TREATING HEMOPHILIA A AND/OR VON WILLEBRAND DISEASE

IPC classification:
A61K 31/70, A61K 31/7004, A61K 31/7008, A61P 7/04
Applicant:
CSL Behring GmbH
Agent:
Beate Peter, CSL Behring GmbH
Status:
GRANT OF PATENT INTENDED
EP11716956

ANTIBODY COMPOSITION OBTAINED BY FRACTIONATION OF PLASMA IMMUNOGLOBULINS AFFINITY CHROMATOGRAPHY ON A SAMBUCUS NIGRA AFFINITY COLUMN

IPC classification:
A61K 39/395, A61P 37/00, C07K 16/00, C07K 16/06
Agent:
Beate Peter, CSL Behring GmbH
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12158933

Prevention of infection

IPC classification:
A61K 38/14, A61K 47/48, C07K 16/12
Applicant:
Beth Israel Deaconess Medical Center Inc
Agent:
Beate Peter, CSL Behring GmbH
Status:
APPLICATION REFUSED
EP14722135

COMPLEX

IPC classification:
A61K 38/37, A61K 47/48, A61P 7/04, C07K 14/755
Agent:
Beate Peter, CSL Behring GmbH
Status:
EXAMINATION REQUESTED
EP14736713

PROCESS

IPC classification:
C07K 1/36, C07K 16/06
Applicant:
CSL Behring AG
Agent:
Beate Peter, CSL Behring GmbH
Status:
GRANT OF PATENT INTENDED
EP15715209

NEBULIZATION OF IMMUNOGLOBULIN

IPC classification:
A61K 9/00, A61K 47/18, A61M 11/00
Applicant:
CSL Behring AG
Applicant:
PARI Pharma GmbH
Applicant:
Medizinische Hochschule Hannover
Agent:
Beate Peter, CSL Behring GmbH
Status:
EXAMINATION REQUESTED
EP15805446

PHARMACEUTICAL PRODUCT WITH INCREASED STABILITY COMPRISING IMMUNOGLOBULINS

IPC classification:
A61K 39/395, A61M 5/178, C07K 1/00, C07K 16/00
Applicant:
CSL Behring AG
Agent:
Beate Peter, CSL Behring GmbH
Status:
Request for examination was made

Please Sign in to use this feature